John Flavin, Portal Innovations CEO, joins 'Fast Money' to talk what we can expect to see from the J.P. Morgan Healthcare ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

About ADARx Pharmaceuticals ADARx Pharmaceuticals, Inc. is a late-stage clinical biotechnology company dedicated to transforming cutting-edge science into next-generation RNA medicines across a wide ...

Pattern Computer®, Inc. (“Pattern” or“the Company”) today announced that Mark R. Anderson, Chairman and CEO, is scheduled to present at the TechBio portion of the Biotech Showcase 2025 investor forum, ...

Investors sell off AMD shares despite the company's pivot to life sciences AI, following a rating downgrade by HSBC that followed a six-month decline in the stock price.

As expected for a growth strategy, most of the assets tend to be invested in the technology, healthcare ... the vast majority of her 20 years at J.P. Morgan on this team as an analyst and then ...

Tony Lee joined the value team in 2018; he covers healthcare, insurance ... who average 22 years of industry experience. J.P. Morgan is a well-resourced, diligent, and responsible steward of ...